The Use of Not-Negative Conclusions to Describe Results of Formally Negative Trials Presented at Oncology Meetings.
rct · Level II
Where this comes from
- Record sourced from PubMed, PMID 32297907.
- Also identified by DOI 10.1001/jamaoncol.2020.0475 and PMC identifier 7163776.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This quality improvement analysis of oral presentations of phase 3 randomized clinical trials evaluates the frequency and risks of emphasizing results of borderline significance.
Medical subject headings
- Clinical Trials, Phase III as Topic
- Communication
- Congresses as Topic
- Randomized Controlled Trials as Topic